Genesis MedTech Group (investor - Corporate Investor)

See something wrong or missing? Let us know
Average round investment:47.64M USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: France SafeHeal
Mostly invests in: France France (1) Hardware (1)

1 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Genesis MedTech Group

Name Criteria
United States Intel Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Hardware, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Netherlands Merck Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States Invus
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Hardware, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
France Adelie Capital
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Hardware, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Denmark Sunstone Life Science Ventures
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
France Creadev
81%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Hardware, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
France MACSF
81%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United States Bicycle Day Ventures
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Hong Kong CR-CP Life Science Fund
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States +ND Capital
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top